| A | B |
|---|
| 1SYR | INJECT THE CONTENTS OF 1 SYRINGE |
| AAA | APPLY TO AFFECTED AREA(S) |
| IM | INTRAMUSCULARLY |
| INJ | INJECT |
| SQ | UNDER THE SKIN |
| U | UNITS |
| AAAT | APPLY TOPICALLY TO AFFECTED AREA(S) |
| AAAS | APPLY SPARINGLY TO AFFECTED AREA(S) |
| AAAE | APPLY EXTERNALLY TO AFFECTED AREA(S) |
| DR | DISCARD REMAINDER |
| S | TEASPOONFUL |
| GT | DROP/DROPS |
| 1VN | INHALE THE CONTENTS OF 1 VIAL VIA NEBULIZER |
| AD | IN THE RIGHT EAR |
| AL | IN THE LEFT EAR |
| AU | IN BOTH EARS |
| EN | IN EACH NOSTRIL |
| INH | INHALE |
| OD | IN THE RIGHT EYE |
| OS | IN THE LEFT EYE |
| OU | IN EACH EYE |
| AFA | INTO THE AFFECTED EAR(S) |
| AFO | INTO THE AFFECTED EYE(S) |
| ZEP15 | INJECT 15MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
| ZEP75 | INJECT 7.5MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
| WEG1 | INJECT 1MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
| WEG025 | INJECT 0.25MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
| TRU150 | INJECT 1.5MG SUBCUTANEOUSLY (UNDER THE SKIN) EVERY 7 DAYS |
| TRU450 | INJECT 4.5MG SUBCUTANEOUSLY (UNDER THE SKIN) EVERY 7 DAYS |
| OZEMSTART | INJECT 0.25MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY FOR 4 WEEKS, THEN 0.5MG ONCE WEEKLY |
| OZEM2 | INJECT 2MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
| MOUN125 | INJECT 12.5MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
| MOUN10 | INJECT 10MG SUBCUTANEOUSLY (UNDER THE SKIN) ONCE WEEKLY |
